Latest Breaking News On - Vincerx pharma daily - Page 1 : vimarsana.com

Vincerx Pharma, Inc (NASDAQ:VINC) Short Interest Down 44 9% in May

Vincerx Pharma, Inc. (NASDAQ:VINC – Get Free Report) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 567,500 shares, a decrease of 44.9% from the April 30th total of 1,030,000 shares. Based on an average trading volume of 927,300 shares, the short-interest ratio is presently 0.6 […]

United statesVincerx pharmaCantor fitzgeraldVincerx pharma company profileExchange commissionVincerx pharma incVanguard group incGet free reportFree reportVincerx pharma daily

Vincerx Pharma, Inc (NASDAQ:VINC) Sees Large Decline in Short Interest

Vincerx Pharma, Inc. (NASDAQ:VINC – Get Free Report) was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 567,500 shares, a decline of 44.9% from the April 30th total of 1,030,000 shares. Based on an average daily volume of 927,300 shares, […]

United statesVincerx pharmaExchange commissionVanguard group incCantor fitzgeraldVincerx pharma incGet free reportFree reportVincerx pharma daily

Vincerx Pharma (NASDAQ:VINC) Announces Earnings Results

Vincerx Pharma (NASDAQ:VINC) Announces Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesVincerx pharmaVanguard group incExchange commissionCantor fitzgeraldVincerx pharma incGet free reportFree reportVincerx pharma daily

Cantor Fitzgerald Reaffirms Overweight Rating for Vincerx Pharma (NASDAQ:VINC)

Cantor Fitzgerald restated their overweight rating on shares of Vincerx Pharma (NASDAQ:VINC – Free Report) in a research report released on Tuesday morning, Benzinga reports. Vincerx Pharma Stock Performance Shares of VINC opened at $0.98 on Tuesday. The stock has a market cap of $20.98 million, a PE ratio of -0.52 and a beta of […]

United statesVincerx pharmaVanguard group incVincerx pharma incRenaissance technologiesCantor fitzgeraldAffinity asset advisorsFree reportMontreal canAsset advisorsGet free reportVincerx pharma daily

Vincerx Pharma s (VINC) Overweight Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Vincerx Pharma (NASDAQ:VINC – Free Report) in a report released on Tuesday morning, Benzinga reports. Vincerx Pharma Price Performance VINC opened at $1.00 on Tuesday. Vincerx Pharma has a one year low of $0.61 and a one year high of $9.37. The company’s 50 day simple […]

United statesVincerx pharmaSusquehanna international groupWalleye capitalVincerx pharma incCantor fitzgeraldVincerx pharma company profileGoldman sachs group incFree reportInternational groupSachs groupPoint capital managementGet free reportVincerx pharma daily